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WHAT THIS PAPER ADDS 
In addition to their cognitive disabilities, children and adolescents with Down syndrome present 
with specific difficulties in speech production which can lead to significantly reduced 
intelligibility. These difficulties, which are often resistant to change through conventional 
methods of intervention, can adversely affect academic achievement, social interactions and 
friendship formation.  They typically persist into adulthood, further impacting on social 
inclusion and putting employment prospects at risk.  Speech and language services for older 
children are often limited despite recent research suggesting that learning can continue 
throughout adolescence and into adulthood in individuals with Down syndrome. 
Electropalatography (EPG) is a visual biofeedback technique which has been successfully used 
to treat intractable speech disorders in a range of clients but there is little published on its 
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efficacy for individuals with Down syndrome.  This paper demonstrates that some children with 
Down syndrome can improve their speech production skills when EPG is used in assessment 
and in intervention.  
The positive response to EPG therapy demonstrated here by individual participants suggests 
that the visual feedback provided by EPG can be a powerful tool in effecting and promoting 
further speech development in both children and adolescents with Down syndrome.    
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ABSTRACT 
 
Background:  Electropalatography (EPG) records details of the location and timing of tongue 
contacts with the hard palate during speech.  It has been effective in treating articulation 
disorders that have failed to respond to conventional therapy approaches but, until now, its use 
with children and adolescents with intellectual/learning disabilities and speech disorders has 
been limited.   
Aims:  This study aimed to evaluate the usefulness of EPG in the treatment of speech 
production difficulties in children and adolescents with Down syndrome (DS) aged 8-18 years. 
Methods:  Twenty-seven children with DS were assessed on a range of cognitive and speech 
and language measures and underwent additional EPG assessment.  Participants were 
randomly allocated to one of three age-matched groups receiving either EPG therapy, EPG-
informed conventional therapy or ‘treatment as usual’ over a 12 week period.  The speech of all 
children was assessed before therapy using the Diagnostic Evaluation of Articulation and 
Phonology (DEAP: Dodd et al. 2002) and re-assessed immediately post- and 3- and 6-month 
post-intervention to measure percent consonants correct (PCC). EPG recordings were made of 
the DEAP assessment items at all time-points. Percent intelligibility was also calculated using 
the Children’s Speech Intelligibility Measure (CSIM: Wilcox and Morris 1999). 
Results: Gains in accuracy of production immediately post-therapy, as measured by PCC, were 
seen for all groups.  Reassessment at 3- and 6-month post-therapy revealed that those who had 
received therapy based directly on EPG visual feedback were more likely to maintain and 
improve on these gains compared to the other groups.  Statistical testing showed significant 
differences between groups in DEAP scores across time-points although the majority did not 
survive post hoc evaluation.  Intelligibility across time-points, as measured by CSIM, was also 
highly variable within and between the three groups, but despite significant correlations 
between DEAP and CSIM at all time-points, no statistically significant group differences 
emerged. 
Conclusions and implications:  EPG was an effective intervention tool for improving speech 
production in many participants. This may be because it capitalizes on the relative strength of 
visual over auditory processing in this client group. The findings would seem to warrant an 
increased focus on addressing speech production difficulties in current therapy.  
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BACKGROUND 
 
Down syndrome (DS) is the most common genetic cause of learning difficulties, accounting for 
almost one third of those with moderate to severe learning disability.  It is identified in 
approximately 1 in 1000 to 1100 live births (World Health Organization 2018) and incidence 
rates, despite screening, are relatively stable.  Over 800 babies are born each year in the UK 
with DS and almost a quarter of a million worldwide. 
 
Children with DS face many developmental challenges.  These include persistent delays in 
expressive language abilities, with these more prevalent than receptive difficulties (Grieco et al. 
2015).  Speech production problems are often considerably greater than would be anticipated 
given levels of both general cognitive ability and expressive language skills (Roberts et al. 2007; 
Naess et al. 2011). Speech production is typically characterized by frequent sound errors, with 
prolonged use of both developmental phonological processes, for example final consonant 
deletion, cluster reduction and stopping of fricatives, and atypical phonological processes, for 
example backing and lateralization (Roberts et al. 2005; Cleland et al.2010), and inconsistent 
whole word productions (Dodd and Thompson 2001).  Errors in speech production are often 
attributed to structural anomalies but severity has been shown to be more directly related to 
difficulties in speech motor control, dysarthria and hypotonia (Kent and Vorperian 2013; 
Rupela, Velleman and Andrianopoulos 2016). In their review of speech impairments in DS, Kent 
and Vorperian (2013) highlight that articulatory errors frequently involve consonants.  Sommers 
et al. (1988) found the most frequently misarticulated speech sounds in a group of individuals 
with DS aged 15 to 22-years were /s/, /d/, / t /, /r/, /z /, / l /, /s/ clusters, /r/ clusters, /n/, and 
/v/.  
 
Difficulties in speech production can lead to significantly reduced intelligibility (Kumin 2006; 
Namasivayam et al. 2013).  This affects between 59% and 95% of those with DS (Kumin 2006).  
Percentage of intelligible words produced by children with DS are variably reported but Rupela 
et al. (2016), in a study of seven children aged between 3;04 and 8;11, reported a range of 
between 26% and 89% compared to 91-99% for typically developing (TD) children between 2;11 
and 5;01.  Wild et al. (2018) also found a difference between male and female speakers in a 
word identification task.  They reported that whilst lay listeners correctly identified more than 
40% of words produced by females with DS by age 9, male speakers did not reach this level 
until age 16.  TD children were fully intelligible by around 6 years of age, again with females 
showing an age advantage.  
 
Variability and inconsistency are also a common feature of speech production in DS (Dodd & 
Thomson 2001; Roberts et al. 2005), exacerbating intelligibility problems.  For some children at 
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least, making themselves understood becomes such an uphill task that spontaneous 
conversation, even with peers, may become very limited (Wishart et al. 2007).  These 
difficulties adversely affect academic achievement, social interactions and friendship formation 
(Hitchcock, Harel, McAllister Byun 2015; Rvachew and Folden 2017).  Full inclusion in society 
and later employment prospects are also potentially at risk (Carr 2008; Kumin and Schoenbrodt 
2016).  
 
In order for children and adolescents with DS to reach their full potential, interventions 
targeting speech at all stages of development are required.  Despite evidence that expressive 
language learning can continue into adolescence (Chapman, Hesketh and Kistler 2002), services 
for older children are often limited, perhaps due to assumptions about a critical period for 
language development and a view that learning plateaus in adolescents with intellectual 
disability (Terband et al. 2018).  A study by Rvachew and Folden (2017), however, which 
provided intervention targeting speech production for a single adolescent with DS, found 
measurable improvements in accuracy, with parents additionally reporting improvements in 
intelligibility. Terband et al. (2018) reported improved intelligibility following intervention in a 
group of adults with intellectual disability which included eleven individuals with DS. This 
supports the view that learning can continue throughout adolescence and into adulthood in 
individuals with DS.  
 
Despite this evidence of continuing improvement in speech in later childhood, Dyke et al. 
(2007) reported that access to SLT services outside of school declines in the teenage years, with 
both families and professionals dissatisfied with the amount of therapy available.  Meyer, 
Theodoros and Hickson (2017) explored the provision of SLT services in Australia for people 
with DS across the lifespan and found that the majority of services were offered to younger 
children, specifically under the age of 7, with 13-17 year olds being identified as the least 
serviced group. Despite articulation and speech intelligibility being addressed by more than half 
the SLTs working with school-aged clients, these areas were also identified as needing yet 
further additional services.   
 
Speech errors in DS are often considered to be intractable as they have typically proved 
resistant to conventional methods of intervention delivered by SLTs (Gibbon et al. 2003; Kumin, 
2006).  Alternative treatment approaches that can better address the needs of this population 
clearly merit exploration.  Recent research suggests that speech therapy using visual bio-
feedback (VBF) can provide an alternative approach to the remediation of persistent speech 
sound disorders in a number of clinical populations (Hitchcock et al. 2017).  Research exploring 
VBF with individuals with DS is limited.  Fawcett, Bacsfalvi and Bernhardt (2008) utilized 
ultrasound VBF in three young adults with DS to remediate errors in the production of /r/.  
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Whilst all participants were reported as beginning to use /r/ in words after 13 or 14 sessions 
this progress was lost when VBF was removed, suggesting problems with long-term 
generalisation.  This is perhaps not surprising given that /r/ is a late acquired and articulatorily 
complex consonant and known to be particularly vulnerable to problems with generalisation 
(Preston et al. 2016).   
 
The study to be reported here utilised electropalatography (EPG) to assess and treat speech 
errors in children and adolescents with DS, using a parallel-group randomized controlled design.  
EPG is a VBF technique which records the timing and location of tongue contact with the hard 
palate during continuous speech.  
 
EPG has been applied in research for both assessment and intervention of speech sound 
disorders in a range of clients, including cleft palate, hearing impairment, dysarthria and DS (for 
a bibliography of EPG studies see Gibbon 2013).  In particular, this technique has been 
successful in resolving persistent speech errors involving lingual consonants, especially in 
individuals whose difficulties were considered to be motor-based (Wood and Hardcastle 2000; 
Gibbon and Wood 2003; Cleland et al. 2009; Wood et al. 2009).  Until now, however, the use of 
EPG with those with a learning disability and a speech disorder has been limited to case studies 
(Gibbon et al. 2003; Hamilton 1993; Wood et al. 2009). Given the agreement in the literature 
that those with DS demonstrate motor speech difficulties (Kent and Vorperian 2013; Rupela, 
Velleman and Andrianopoulos 2016), and that nine of the ten most frequently misarticulated 
sounds identified by Sommers et al. (1988) involve lingual articulation, a VBF technique such as 
EPG would seem to offer a well-tailored alternative to traditional auditory-based therapy.  EPG 
has minimal cognitive and language demands and also capitalizes on the known relative 
strength of visual versus auditory processing ability in children with DS (see e.g. Fidler & Nadel 
2007; Ringenbach et al. 2012).   Weismer, Yunusova and Bunton’s (2012) suggestion that 
tongue control is strongly related to speech intelligibility further strengthens the argument for 
exploring the utility of a VBF technique to target lingual errors in children with DS.   
 
EPG requires the speaker to wear a dental plate (see Figure 1), similar to an orthodontic brace, 
which fits snugly against the hard palate (Gibbon and Wood 2010).  Embedded into the dental 
plate are 62 electrodes whose position is registered on a computer screen when the tongue 
touches them.  EPG is a particularly valuable diagnostic tool because it gives objective and 
detailed analysis of an individual’s articulation patterns and may identify errors which cannot 
be detected by perceptual analysis alone but may be vital for accurate diagnosis and effective 
intervention (Wood and Hardcastle 2000). In addition to providing vital diagnostic information, 
EPG can be used in therapy to enable the speaker to visualise their tongue contact with the 
hard palate in real time, providing otherwise inaccessible information which can be used to 
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correct erroneous motor programmes. The speech and language therapist (SLT) selects a target 
articulation pattern characteristic of a particular sound currently being incorrectly produced 
and displays this on a computer screen.  During the therapy session, the client attempts to copy 
this correct articulation by monitoring their own contact patterns in real time (see Figure 2).  
 
 Figure 1: EPG palate on dental cast 
 
 
Figure 2:  A client attempts to copy the target articulation which is displayed on the right-hand 
side of the computer screen. The left-hand pattern is the client’s attempts to match the target. 
 
AIMS 
 
This research aimed to evaluate both the efficacy and effectiveness of EPG-based and EPG-
informed therapy in improving speech production in school-aged children with Down 
syndrome. Given the documented relative strengths in visual processing abilities we predicted 
that those receiving EPG-based therapy would make greater progress over the intervention and 
follow-up period than those receiving therapy that was only EPG-informed. Given the additional 
information offered by EPG assessment it was predicted that progress in both these groups 
would exceed that made by a ‘treatment as usual’ group.  
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METHODS AND PROCEDURES 
 
Participants  
Children with DS aged 8-18 years were recruited to the project primarily from a participant 
database already held by one of the authors but also with help from the Scottish Down’s 
Syndrome Association and NHS colleagues.  All participants were required to present with 
errors involving linguapalatal consonants and to have a minimum age-equivalent cognitive level 
of 3 years.  Additional inclusion criteria were: (i) English as a first language, (ii) ability to produce 
at least single words, (iii) no significant hearing loss (aided threshold >40 dB), (iv) no co-morbid 
diagnosis of autism, and (v) no pacemaker fitted (a precautionary measure as any possible 
cross-interference between pacemaker and EPG use had not yet been clinically evaluated).  
 
Fifty-seven families were initially approached.  Fourteen were not interested in participating, 
lived too far away to make participation feasible, or anticipated family or school difficulties in 
committing to 12 weeks of clinic-based therapy sessions.  The 43 remaining families were either 
visited or made a preliminary visit to the clinic.  In 9 cases the child failed to meet the full 
inclusion criteria detailed above, in 5 there were other grounds for withdrawing at an early 
stage (e.g. palate suitability issues, work commitments, transport difficulties), and in 2 reasons 
for withdrawing were not given by families. 
 
Twenty-seven children and young people with DS living in the central belt of Scotland were 
finally recruited to the study, 16 boys and 11 girls.  Participants were aged between 8 years 3 
months and 18 years 9 months (mean 13 years 5 months, SD 3 years 1 month).  None of the 
participants had previously undergone EPG assessment or intervention.  
 
Ethical approval 
Full ethical approval for recruitment procedures and the study design was granted by the NHS 
Lothian Research Ethics Committee and Queen Margaret University Research Ethics committee.  
 
Assessment battery 
All children initially completed a battery of standardised speech, language and cognitive 
assessments and a series of EPG-based assessments of speech production. Speech and 
language tests were carried out by a qualified speech and language therapist (SLT) and 
cognitive assessments were carried out by a child psychologist, with each blind to outcomes 
from the other assessment arm.  Most children completed the test battery in three, one-hour 
sessions, with breaks as requested by either the child or their carer.  
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The pre-therapy assessment battery included the following: 
Cognitive Ability:  Wechsler Preschool and Primary Scale of Intelligence (WPPSI-IIIUK: 
Wechsler 2003) – verbal and performance age equivalent (AE*) scores reported. 
Receptive vocabulary:  British Picture Vocabulary Test (BPVS II: Dunn et al. 1997) – AE scores 
reported.  
Receptive and Expressive language:  Clinical Evaluation of Language Fundamentals Preschool 
(CELFP-UK, Wiig, Secord & Semel 1992) – receptive and expressive language AEs reported.   
Oromotor Function:  Clinical Assessment of Oropharyngeal Motor Development in Young 
Children (Robbins & Klee 1987) - structure and function of the vocal tract (including 
diadochokinesis - DDK) scored as either adult-like (2 points), approaching adult-like (1 point) 
or absent (0); raw scores converted to percentages.  
Speech production: Phonology subtest of Diagnostic Evaluation of Articulation and Phonology 
(DEAP: Dodd et al. 2002) - percentage consonants correct (PCC) reported.  
Intelligibility: Children’s Speech Intelligibility Measure (CSIM: Wilcox & Morris 1999 - chosen 
because many participants spoke in only single words or short phrases) - percentage of 
correctly-identified words reported by an adult listener unfamiliar with the child. 
(* AEs calculated as test norms based on younger, typically-developing children.)   
 
The DEAP and CSIM data served as baseline data against which therapy outcomes were to be 
measured.  The first assesses accuracy of individual speech sounds whereas the second assesses 
intelligibility at single word level.  The CSIM requires the child to imitate 50 words produced by 
the SLT which are then played to an unfamiliar adult listener. The imitated words are chosen at 
random from a choice of 200 word lists. The listener has to choose, from a list of twelve similar 
sounding words, the item they hear. The number of correctly identified words is multiplied by 
two to give a percentage of intelligibility.  Given the extended period of the study it was not 
possible to use the same adult listener throughout.  All four adult listeners were qualified SLTs 
and were allocated to participant recording sequentially as each replaced the other over the 
course of the study.  Both the DEAP and the CSIM were re-administered to all groups immediately 
post-therapy, with these two measures taken again 3 and 6 months later.  As before, testing was 
spread over as many sessions as individual circumstances dictated, typically 1-2 at these later 
time-points. 
During administration of the DEAP, all children wore an EPG palate. To ensure speech 
production was not audibly affected, each child was required to wear the palate for a total of 2-
4 hours over a one-week period prior to assessment to ensure that they had become 
accustomed to the feel of the palate in the mouth (McAuliffe, Robb, & Murdoch 2007). All 
DEAPs were audio recorded and were transcribed using broad phonetic transcription by a SLT 
blind to outcomes from other assessment measures and groupings.  CSIMs were similarly blind 
rated.   
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To check reliability of DEAP transcriptions, 50 words from four participants (200 words in total) 
were selected at random and transcribed by a different SLT, with transcriptions then compared 
on a segment-by-segment basis.  Mean agreement was 88.2% ranging from 85.6% to 90.6% 
across the four speakers.   
 
Design 
A single-blinded, parallel RCT design was adopted.  A sequence was generated using a random 
number generator in Excel to allocate participants to one of three groups, two therapy groups 
and one control group.  Allocation concealment was through use of opaque envelopes which 
were handed to the SLT on completion of the assessment battery.  As recruitment to groups 
progressed age-spread within each group was monitored to ensure the three groups were 
broadly equivalent, but no adjustment to group was required.  
 
A wide range of speech errors was seen in each group, both developmental and non-
developmental phonological processes, articulation errors and increased variability of 
productions.  Errors from the first 15 children recruited to the study are described in detail in 
Cleland et al. (2009), the remaining children showed a similar range of errors.  Children in Group 
1 received EPG therapy whereas those in Group 2 received speech therapy based on current 
practice.  The same SLT delivered the therapy to both groups. The EPG assessment (also 
administered by the treating SLT) provided additional objective information that would not 
usually be available. This allowed the SLT to identify speech errors not detected through auditory 
analysis alone and set therapy targets accordingly for both groups.  Children in Group 3 received 
no therapy within this study, thereby acting as a control group for maturational gains.  The 
management of participants in Group 3 continued as usual outside of the study as they did for 
Groups 1 and 2. Those who had been allocated to Groups 2 and 3 were offered EPG therapy 
following completion of the study.   
 
Table 1 provides a summary of all standardised assessment results for all participants by group 
at the pre-therapy stage.  A one-way analysis of variance revealed no statistically significant group 
differences in either DEAP or CSIM scores at p<0.05: F (2, 24) = 0.538, p = 0.591; F (2, 24) = 0.501, 
p = 0.613 respectively.  
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    DEAP CSIM BPVS-II CELFP-UK  WPPSI-IIIUK 
 Participant Age Sex PCC % AE CELF-R CELF-E RK VMA PMA 
G
R
O
U
P
 1
 
EP
G
 t
h
er
ap
y 
DS1 9;10 M 59 66 5;06 4;09 4;00 84.62 4;08 5;09 
DS2 10;01 M 38 32 3;00 3;05 2;09 66.35 3;11 4;05 
DS3 10;02 M 66 84 6;10 3;10 4;05 90.38 <4;00 >5;05 
DS4 10;11 M 70 66 5;02 4;02 3;06 81.73 >5;01 >5;09 
DS5 11;07 F 67 72 5;05 3;11 3;00 79.81 4;08 6;04 
DS6 14;10 M 70 46 5;02 3;07 3;10 88.46 4;03 >6;05 
DS7 14;11 M 59 46 7;03 4;10 4;00 69.23 5;07 >7;02 
DS8 15;09 F 83 80 4;08 4.02 3;01 85.58 4;08 >7;01 
DS9 18;09 M 81 81 4;03 4;00 3;05 81.73 5;03 <4;01 
G
R
O
U
P
 2
 
EP
G
-i
n
fo
rm
ed
 c
o
n
ve
n
ti
o
n
al
 
th
er
ap
y 
DS10 8;03 F 63 50 4;00 3;03 2;10 63.46 <4;01 <4;03 
DS11 9;02 F 82 72 5;11 4;02 5;02 79.81 5;09 5;10 
DS12 10;05 M 73 82 5;05 4;02 3;08 80.77 4;05 <5;08 
DS13 13;01 F 74 80 6;06 3;10 3;09 81.73 5;00 6;03 
DS14 15;06 F 78 92 4;03 3;08 3;03 82.69 <4;10 >5;05 
DS15 15;06 M 72 54 5;10 4;03 3;03 72.12 5;05 >5;11 
DS16 16;05 M 47 43 2;11 2.09 2;06 61.54 <4;01 <4;06 
DS17 16;06 F 33 20 6;10 4;00 3;10 51.92 5;10 >7;02 
DS18 17;09 F 41 36 2;10 - - 56.73 <4;01 <5;11 
G
R
O
U
P
 3
 
Tr
ea
tm
en
t 
as
 u
su
al
 
DS19 9;06 F 81 82 4;04 3;04 3;03 90.38 <4.01 <5;04 
DS20 9;06 F 43 40 3;03 3;03 2;11 72.12 <4;01 5;01 
DS21 11;07 M 43 38 4;08 3;05 3;00 61.54 <4;01 >6;09 
DS22 13;00 M 87 82 6;04 4;06 4;00 91.35 >6;03 >6;09 
DS23 13;10 F 84 90 5;10 4;04 3;08 79.81 5;06 6;01 
DS24 15;08 F 40 - 3;01 3;01 2;07 68.27 <4;01 <5;01 
DS25 15;09 F 61 37 3;03 3;01 2;07 70.19 <4;01 >6;01 
DS26 16;03 M 54 52 3;10 3;06 2;10 66.35 <4;01 5;02 
DS27 17;05 M 19 24 3;03 2;10 3;00 54.81 <4;01 >7;02 
Table 1: Standardised assessment results for all participants arranged by group.  
Key to abbreviations: DEAP: Diagnostic Evaluation of Articulation and Phonology; PCC: 
percentage consonants correct; CSIM: Children’s Speech Intelligibility Measure; BPVS-II: British 
Picture Vocabulary Scale – II; CELFP-UK: Clinical Evaluation of Language Fundamentals - Preschool 
UK; CELF-R: CELF Receptive Language; CELF-E: CELF Expressive Language; RK: Robbins and Klee 
clinical assessment of oropharyngeal motor development in young children; WWPPSI: Wechsler 
Preschool and Primary Scale of Intelligence; VMA: verbal mental age; and PMA: performance 
mental age. 
 
Intervention 
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For Groups 1 and 2, all therapy was delivered in one hour sessions, twice weekly, over a period 
of 12 weeks, by the same qualified SLT who had previously undergone training in the use of EPG. 
The parent or carer was present at each appointment.  The SLT first undertook a phonological 
process analysis of the initial DEAP assessment.  Both phonological and phonetic errors were 
identified and errors that occurred less than 3 times were discounted (Dodd et al. 2002).  Therapy 
targeted speech errors that were considered most disruptive to intelligibility and typically took a 
developmental approach. For Group 1 this was restricted to lingual mis-articulations as therapy 
was based on the visual biofeedback provided by EPG; some errors identified by the process 
analysis could not therefore be targeted.  Therapy followed a basic articulatory hierarchy starting 
with the target phoneme in CV or VC structure using a facilitating vowel (for example using a back 
vowel for velars) and progressing to other vowels and CVC structures and continuing to more 
complex word structures.  Where progress indicated such, the SLT moved to phrase and sentence 
level.  Since individuals with DS often present with poor phonological awareness and speech 
perception skills, direct work on speech production was supplemented with some input activities 
(for more detail see Cleland et al.’s 2009 preliminary report on early entrants to this study). Once 
a new articulation had been established and was secure in a variety of different contexts, visual 
feedback was gradually reduced in line with EPG protocol (Gibbon and Wood 2010). 
 
Targets for Group 2 were less constrained and drew on information provided by the EPG 
assessment.  An eclectic approach was adopted, drawing on both input and output activities and 
more typical of intervention for individuals with specific speech disorders (Joffe and Pring 2008); 
a core vocabulary approach was taken for those presenting with inconsistent speech productions. 
Other aspects of speech production such as rate, prosody and loudness were not targeted in 
either group.  Therefore the goals for Group 1 and 2 differed due to constraints imposed by EPG 
on target selection and treatment methods.  For both Groups 1 and 2 the level and dosage of 
intervention was adjusted to individual participant’s needs and abilities and daily home practice 
of 10-15 minutes each day was recommended.  Participants in Group 1 had the use of a portable 
training unit (PTU) to provide continued visual feedback at home but no record of home practice 
compliance was recorded for either group. 
 
Statistical Analysis 
In order to evaluate the effectiveness of EPG-based and EPG-informed therapy in improving 
speech production, the PCC scores from the DEAP assessment and the CSIM scores were 
investigated across the four time-points: pre-therapy, post-therapy, 3-month post-therapy and 
6-month post-therapy. 
Following Murray, McCabe and Ballard (2015), comparisons were made from the following 
time-points to investigate change immediately after intervention and to investigate 
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maintenance of gains at later stages: (1) pre-therapy to post-therapy (to assess impact of 
intervention), (2) post-therapy to 3-month post-therapy (to assess short-term maintenance of 
any intervention effects), and (3) post-therapy to 6-month post-therapy (to test for longer-term 
gains). 
Post-therapy data were not available for all participants across all measures at all time-points. 
One participant withdrew from the study prior to all post-therapy assessments, some data 
points were missing due to clients’ cancelling and being unable to reschedule within the 
planned time frame, and in a small number of cases, irretrievable corruption of data files 
produced missing cells (see Table 2).  
 
 Pre-therapy Post-therapy 3m post-therapy 6m post-therapy 
 DEAP CSIM DEAP CSIM DEAP CSIM DEAP CSIM 
Group 1 9 9 9 9 7 7 9 6 
Group 2 9 9 9 8 8 8 8 6 
Group 3 9 8 7 6 6 6 8 4 
Table 2: Number of participants at each time-point (maximum n in each group = 9) 
 
Due to the small and varying numbers of participants across time-points, Shapiro-Wilks tests of 
normality were performed on the distribution of the DEAP and CSIM data (see Table 3).  
 
 Pre-therapy Post-therapy 3m post-therapy 6m post-therapy 
 DEAP PCC CSIM DEAP PCC CSIM DEAP PCC CSIM DEAP PCC CSIM 
Group 1 .368 .185 .028 .586 .784 .039 .078 .875 
Group 2 .156 .368 .555 .369 .328 .164 .094 .875 
Group 3 .454 .157 .429 .588 .398 .844 .664 .012 
Table 3: Shapiro-Wilk’s test of normality p values for both measurements at each time-point 
 
As noted in Table 3, data for each measure were not normally distributed in all groups at different 
time points. A within-groups non-parametric statistical test for repeated measures (Friedman’s 
test) was therefore performed for each group across the 4 time-points. Confidence intervals were 
set at 95% with a p value of <.05. Post-hoc investigations were performed using Wilcoxon signed-
rank tests.  As this did not allow for a comparison between treatment groups, a Kruskal-Wallis H 
test was also applied to investigate group differences. Group comparisons were performed on 
assessment scores using change scores for each planned comparison (i.e. the post-therapy score 
minus the pre-therapy, 3-month post-therapy minus post-therapy, 6-month post-therapy minus 
post-therapy).  Post-hoc analysis was performed using Mann-Whitney U tests.  
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A Spearman’s rank-order correlation was run to investigate the relationship between the DEAP 
PCC and the CSIM scores over time as previous research has shown a relationship between 
improvements in PCC and intelligibility (McLeod, Harrison and McCormack 2012). 
 
RESULTS 
Means and standard deviations for DEAP PCC and CSIM scores at each time-point are presented 
in Table 4. 
 
Pre-therapy Post-therapy 3m post-therapy 6m post-therapy 
Group 
1 
Group 
2 
Group 
3 
Group 
1 
Group 
2 
Group 
3 
Group 
1 
Group 
2 
Group 
3 
Group 
1 
Group 
2 
Group 
3 
DEAP 
PCC 
65.9 
(13.4) 
62. 6 
(17.8) 
56.9 
(23.3) 
76.2 
(16.4) 
72.0 
(15.7) 
61.4 
(26.4) 
77.0 
(13.3) 
66.6 
(19.5) 
65.0 
(20.1) 
80.8 
(13.4) 
70.8 
(16.0) 
66.9 
(18.5) 
CSIM 
63.7 
(18.3) 
58.8 
(24.1) 
55. 6 
(25.3) 
67.5 
(22.0) 
56.5 
(22.1) 
54.7 
(17.6) 
57.7 
(21.6) 
60.0 
(27.8) 
45.0 
(21.9) 
69.3 
(13.7) 
60.7 
(21.3) 
56.0 
(22.7) 
Table 4: Mean and standard deviation for DEAP PCC and CSIM scores at each time-point for 
each group. 
Table 4 and Figure 3 indicate that all intervention groups showed an increase in DEAP PCC 
scores from pre- to post-therapy. Group 1 and Group 3 continued to show an increase in DEAP 
PCC scores at 3-month post-therapy and at 6-month post-therapy. CSIM scores increased only 
for Group 1 between pre- and post-therapy but this was not maintained at the 3-month post-
therapy time-point, although an increase in intelligibility was seen at 6-month post-therapy 
(Figure 4).  
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Figure 3: Boxplot showing median and IQR values for the Diagnostic Evaluation of Articulation 
and Phonology (DEAP) PCC scores for Group 1 (EPG-therapy), Group 2 (EPG-informed 
conventional therapy) and Group 3 (treatment as usual) across the four time-points. 
 
 
Figure 4: Boxplot showing median and IQR values for the Children’s Speech Intelligibility 
Measure (CSIM) for Group 1 (EPG-therapy), Group 2 (EPG-informed conventional therapy) and 
Group 3 (treatment as usual) across the four time-points. 
 
Within Group Comparisons 
DEAP PCC scores 
A Friedman’s test identified a statistically significant difference in DEAP PCC across the four 
time-points for Group 1, χ2 (3) = 14.603, p = .002. Post-hoc analysis with Wilcoxon signed-rank 
tests was conducted.  Although scores were noted to rise at each subsequent time-point, there 
were no significant differences between the post-therapy and 3-month post-therapy scores (Z = 
-1.69, p=.091), nor between the post-therapy and 6-month post-therapy scores (Z = -1.689, 
p=.091). However, there was a statistically significant increase of scores from pre-therapy to 
post-therapy (Z = -2.668, p= .008, effect size (Cohen’s d) r = .63).  
 
Group 2 DEAP PCC scores also showed a statistically significant difference across the time-
points, χ2 (3) = 10.271, p = .017. Post-hoc analysis identified decreased scores from post-
therapy to 3-month post-therapy but these were not significant (Z = -1.546, p=.122). This was 
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the same for the post-therapy and 6-month post-therapy comparison (Z = -1.262, p=.207). 
However, there was a statistically significant increase of scores from pre-therapy to post-
therapy (Z = -2.670, p= .008, effect size (Cohen’s d) r = .63). 
 
DEAP PCC scores also differed significantly across time-points for Group 3, χ2 (3) = 14.6, p = 
.002. Post-hoc analysis found that none of the time-point comparisons presented as statistically 
significant: pre-therapy and post-therapy (Z = -1.992, p=.046), post-therapy and 3-month post-
therapy (Z = -1.363, p=.173), post-therapy and 6-month post-therapy (Z = -1.101, p=.271). 
CSIM scores 
None of the group CSIM scores showed a statistically significant difference across the time-
points. 
Between Group Comparisons 
DEAP PCC scores 
DEAP PCC difference scores from pre- to post-therapy were evaluated using a Kruskal-Wallis H 
test which showed that there was no statistically significant difference between intervention 
groups at this time-point: χ2 (2) = 1.830, p = .401. The same test was completed for the post-
therapy and 3-month post-therapy difference scores. There was a statistically significant 
difference for groups, χ2 (2) = 6.114, p = .047, with a mean rank DEAP PCC score of 12.86 for 
Group 1, 6.81 for Group 2 and 14.42 for Group 3. This difference did not survive post hoc 
Mann-Whitney U testing which found no significant difference between Group 1 and Group 3 
(U = 14.5, p=.366), Group 2 and Group 3 (U =10, p=.081), and Group 1 and Group 2 (U =25.0, 
p=.190). A significant difference was noted between groups at the post-therapy to 6-month 
post-therapy comparison point, χ2 (2) = 6.702, p = .035, with a mean rank DEAP PCC score of 
14.72 for Group 1, 7.25 for Group 2 and 15.64 for Group 3. Post-hoc Mann-Whitney U testing 
found significant differences between Group 1 and Group 2 (U = 13.0, p=.027 with an effect size 
of (Cohen’s d) r= -.42), between Group 2 and Group 3 (U=9.0, p=.029, effect size (Cohen’s d) r=-
.42), but not between Group 1 and Group 3 (U = 28.5, p=.75). 
 
CSIM scores 
CSIM difference scores were tested in the same way as the DEAP PCC scores above. There was 
no statistically significant difference between intervention groups, χ2 (2) = .386, p = .825 for 
time-point 1 (pre-therapy vs post-therapy), time-point 2 (post-therapy vs 3-month post-
therapy), χ2 (2) = 3.1043, p = .218, or time-point 3 (post-therapy vs 6-month post-therapy), χ2 
(2) = 1.043, p = .594. 
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Relationship between PCC and intelligibility 
A Spearman’s rank-order correlation to investigate the relationship between DEAP PCC scores 
and CSIM scores over time showed a strong, positive association between the measures at each 
time point (see Table 5). 
 
Measure Pre-therapy Post-therapy 3-month post-therapy 6-month post-therapy 
DEAP PCC 
* CSIM 
r = .799, p <.01 r = .771, p <.01 r = .710, p <.01 r = .753,  p <.01 
Table 5: Spearman’s rank-order correlation showing the relationship between DEAP PCC and 
CSIM scores over time. 
 
Maintenance of Gains 
Further investigation of gains was carried out by plotting the differences in group mean DEAP 
PCC and CSIM mean scores between pre-therapy and each subsequent time-point (pre- to post-
therapy, pre- to 3-month post-therapy and pre- to 6-month post-therapy. In Figures 5 and 6, 
the pre-therapy scores were set to zero for all groups. 
 
Figure 5:  Change in mean DEAP PCC difference scores over time for Groups 1-3  
As Figure 5 shows, DEAP PCC difference scores for Groups 1 and 3 presented a similar pattern 
over time in that gains were seen at all three comparison points.  However the gains at post-
therapy, at 3-month post-therapy, and 6-month post-therapy were noticeably greater in Group 
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1, with Group 3 showing a more linear progression.  In contrast, following initial gains from pre-
therapy to post-therapy, Group 2 gains were not maintained over the following 3 months and 
despite an uplift in scores between 3- and 6-month post-therapy, overall scores remained lower 
than those achieved immediately post-therapy, indicating that some of the gains made during 
therapy had been lost. 
In contrast, only Group 1 showed an increase in CSIM scores from pre- to post-therapy.  
Although mean scores decreased sharply between pre-therapy and 3-month post-therapy, 
gains were recovered by 6-month post-therapy, resulting in an overall post-therapy gain of 5.6.   
Groups 2 and 3 both showed an initial small decrease in mean scores between pre- and 
immediately post-therapy time-points, Group 2 then showing gains at both subsequent 
comparison points, resulting in a final overall gain of 1.9.  Group 3 scores continued to decrease 
post-therapy, recovering to some extent latterly, but resulting in only a marginal overall gain of 
0.4.   
 
Figure 6: Change in mean CSIM difference scores over time for Groups 1-3 
Individual scores 
Given the exceptionally high variability in group scores on outcome measures at all 4 time-points 
(see Table 4), changes in PCC scores were also examined at the individual level to look for any 
trends across time-points that might not have been statistically detectable due to small numbers 
and this high variability (see Table 6).  CSIM scores were not considered at this level due to the 
number of missing data points post-therapy. 
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From Table 6, it can be seen that all 9 participants in the two therapy groups, Groups 1 and 2, 
showed improved PCC scores immediately post-therapy; in Group 3, 5 out of the 7 participants 
for whom data were held also improved on their initial scores at this time-point.  In terms of 
maintenance of these gains, 6 out of 7 Group 1 participants maintained and showed further 
improvements in PCC scores at the 3-month post-therapy comparison point and 6 at the final, 6-
month post-therapy comparison point; total gains over the 9 month of the study ranged between 
6 and 28 percentage points in Group 1.  In contrast, only 2 out of 8 Group 2 participants 
maintained and increased scores at the 3-month post-therapy comparison point; overall, 3 out 
of 8 participants had maintained or increased their PCC scores at the end of the study, but total 
gains over the 9 months were generally much lower than in Group 1, ranging between 2 and 10 
percentage points.  Group 3 did not receive therapy as part of the study but 5 out of 7 participants 
showed improved PCC scores at post-therapy, 4 out of 6 at 3-month post-therapy, and 6 out of 7 
at 6-month post-therapy; overall, 7 improved their PCC scores over the course of the study, with 
gains ranging from 6-23 percentage points.  
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  DEAP PPC scores CSIM scores 
  Pre-
therapy 
Post-
therapy 
3m post-
therapy 
6m post-
therapy 
Pre-
therapy 
Post-
therapy 
3m post-
therapy 
6m post-
therapy 
G
R
O
U
P
 1
 
EP
G
 t
h
er
ap
y 
DS1 59 66 (+7) 68 (+9) 77 (+18) 66 62 (-4) 66 (+/-0) 62 (-4) 
DS2 38 41 (+3) 54 (+16) 54 (+16) 32 26 (-6) 14 (-18) - 
DS3 66 87 (+21) 93 (+27) 94 (+28) 84 94 (+10) 74 (-10) 92 (+8) 
DS4 70 86 (+16) 87 (+17) 80 (+10) 66 78 (+12) 74 (+8) 64 (-2) 
DS5 67 75 (+8) 78 (+11) 89 (+22) 72 58 (-14) 46 (-26) 76 (+4) 
DS6 70 90 (+20) 86 (+16) 88 (+18) 46 - - - 
DS7 59 65 (+6) 73 (+14) 65 (+6) 46 54 (+8) 60 (+14) 52 (+6) 
DS8 83 88 (+5) - 90 (+7) 80 82 (+2) 70 (-10) - 
DS9 81 88 (+7) - 90 (+9) 81 86 (+5) - 70 (-11) 
G
R
O
U
P
 2
 
EP
G
-i
n
fo
rm
ed
 
co
n
ve
n
ti
o
n
al
 t
h
er
ap
y 
DS10 63 68 (+5) 69 (+6) 71 (+8) 50 54 (+4) 58 (+8) - 
DS11 82 94 (+12) 87 (+5) 84 (+2) 72 - - - 
DS12 73 76 (+3) 83 (+10) 75 (+2) 82 84 (+2) 90 (+8) 74 (-8) 
DS13 74 85 (+11) - 74 (+/-0) 80 80 (+/-0) - 94 (+14) 
DS14 78 85 (+7) 84 (+6) 88 (+10) 92 70 (-22) 84 (-8) 64 (-28) 
DS15 72 79 (+7) 75 (+3) 81 (+9) 54 56 (+2) 66 (+12) 52 (-2) 
DS16 47 51 (+4) 47 (+/-0) 46 (-1) 43 54 (+11) 44 (+1) 44 (+1) 
DS17 33 45 (+12) 34 (+1) - 20 18 (-2) 8 (-12) - 
DS18 41 70 (+29) 54 (+13) 47 (+6) 36 36 (+/-0) 44 (+8) 36 (+/-0)) 
G
R
O
U
P
 3
 
Tr
ea
tm
en
t 
as
 u
su
al
 
DS19 81 - - 70(-11) 82 - - - 
DS20 43 43 (+/-0) 51 (+8) 50 (+7) 40 58 (+18) 54 (+14) 46 (+6) 
DS21 43 - - - 38 - - - 
DS22 87 95 (+8) 93 (+6) 93 (+6) 82 74 (-8) 62 (-20) 90 (+8) 
DS23 84 94 (+10) - 90 (+6) 90 74 (-16) - - 
DS24 40 59 (+19) 49 (+9) 60 (+20) - 42 10 46 
DS25 61 60 (-1) 79 (+18) 73 (+12) 37 40 (-3) 42 (+5) 42 (+5) 
DS26 54 58 (+4) 75 (+21) 77 (+23) 52 50 (-2) 70 (+18) - 
DS27 19 21 (+2) 43 (+24) 33 (+14) 24 30 (+6) 32 (+8) - 
Table 6:  Raw DEAP PCC and CSIM scores for each participant at the 3 comparison time-points. Numbers in brackets show gains from 
pre-to post-therapy, pre- to 3-month post-therapy, and pre- to 6-month post-therapy. 
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DISCUSSION   
This study aimed to investigate the use of EPG in the treatment of speech production errors in 
27 children and young people with DS.  Participants were randomly assigned to one of three 
age-matched groups, with Groups 1 and 2 receiving clinic-based, bi-weekly therapy over a 12 
week period.  Therapy for Group 1 directly utilised EPG visual biofeedback, Group 2 received 
conventional therapy informed by pre-therapy EPG assessment and Group 3 served as the 
‘treatment as usual’ control group.  Speech production and intelligibility were assessed in all 
groups at 4 time-points, over a period of 9 months. As prior single-case studies (Gibbon et al. 
2003; Wood et al. 2009) had demonstrated that EPG could successfully resolve persistent 
speech sound errors in children with DS, it was predicted that progress would be greatest in 
Group 1 and least in Group 3. 
 
Recent overviews of the field emphasise the need for RCTs of developmental speech and 
language disorders but it has to be acknowledged that achieving this standard of evidence in 
practice, in populations of limited size and showing high intra group variability, is always going 
to be challenging.  Although our results did not reach statistical significance this study supports 
earlier findings that EPG can be a successful intervention technique for children with DS and 
that on some measures it can be more effective than conventional therapy.  Reassessment at 3 
and 6-month post-therapy revealed that those who had received therapy based directly on EPG 
visual feedback were more likely to maintain and improve on these gains compared to those 
who received EPG-informed conventional therapy or no therapy. This suggests that the VBF 
afforded by the EPG is a powerful tool in effecting and promoting further speech development.  
 
Despite the rigour of the design, the respectable sample size and the length of the monitoring 
period, the findings from this study were not straightforward to interpret and in many respects 
have raised more questions than answers.  In terms of statistical analyses, the lack of 
statistically significant differences between the groups on both PCC and CSIM measures were 
contrary to expectation.  From Table 4 and Figures 3 and 4, it is evident that the variability in 
scores was extremely large in all groups and this, plus the unavoidably small sample, inevitably 
decreased the chances of identifying statistically significant differences post-therapy with 
outcome measures used here.  The gaps in data sets at later time-points also presented 
obstacles to statistical analyses.  Despite the resources and effort being put into the study, 
these gaps in data collection were perhaps unsurprising, especially in Group 3.  All families 
agreed to take part in our study because of their concerns about their child’s speech and as 
such all hoped to be assigned to one of the therapy arms.  For those randomly assigned to 
Group 3, no clinic-based therapy was on offer and there was therefore not the same incentive 
to attend subsequent appointments.   
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The measures we used to track changes in speech production and intelligibility in each child 
over 9 months are perhaps worth reconsidering at this point. We used percentage of 
consonants correctly produced using the phonology subtest of the DEAP.  Whilst this is 
common in clinical and research practice, this measures generalisation in changes in speech 
production rather than change related to specific therapy targets.  The subtest consists of 141 
possible consonant productions which cover all English consonants in syllable initial and final 
position.  Each sound targeted in therapy only appears at most twice as a singleton consonant 
in the assessment (less if the child fails to produce certain words) and some will appear in 
consonant clusters. Therapy case notes revealed that in Groups 1 and 2, between 1 and 4 
sounds were targeted during the 12 weeks of therapy depending on the individual’s profile and 
progress during therapy.  Any changes in DEAP scores identified might therefore actually 
represent quite significant growth.  Word lists designed to probe segments in varying 
phonotactic environments would have provided more detailed information on the areas of 
speech sound production specifically targeted (see Cleland and Scobbie 2018), however, and 
should be considered in future studies.  
 
Cleland and Scobbie (2018) have recently brought into question the usefulness of classifying 
segments within words as correct or incorrect as it can obscure subtle underlying changes that 
may be occurring in speech production. They identified changes in lingual activity using 
ultrasound visual biofeedback therapy (U-VBF) which highlighted improvements in speech 
production not captured through categorical judgements such as those required to generate 
PCC scores.  It might therefore be useful to look in further detail at EPG measures for each 
group at each time point and specifically at those phonemes targeted in therapy. Additional 
single-word EPG data was collected at all four time points which would lend itself to this type 
analysis and might provide more detail on accuracy and variability specific to therapy targets.  
 
Probably the most surprising finding from this study concerned participants in Group 3 who 
were receiving no direct therapy as part of this study, yet made gains in speech production that 
appeared statistically, at least, similar to the other two groups.  This group was intended to 
serve as a control for maturational change.  Results of standardised assessments were shared 
with referring SLTs following initial assessment for all children to avoid a situation where tests 
with test-retest constraints were accidentally repeated.  It is possible that this assessment 
report increased the focus on speech for participants which may have influenced intervention 
outside of the study.  
 
It is generally accepted that if speech production can be improved then improvements in 
speech intelligibility will follow.  In the current study, due to missing CSIM data at post-therapy 
time points in each group, it was impossible to investigate this relationship.  However, on visual 
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inspection of Figures 5 and 6, Group 1 and Group 2 (for which data were most complete) 
showed a different pattern of performance.  For Group 1, there was a mirroring of performance 
on the two outcome measures, from pre-therapy to post-therapy and from 3-month post-
therapy to 6-month post-therapy, with an overall gain in both PCC scores and CSIM scores from 
pre-therapy to 6-month post-therapy. However, in Group 2 the initial gain in PCC score was not 
reflected by gains in CSIM (which in fact decreased) although there was an overall gain for both 
measures when differences in post- therapy and 6-month post-therapy scores were calculated. 
The difficulties of measuring intelligibility have been well documented (Miller 2013), specifically 
what people are referring to when using this term and how it might be assessed.  The CSIM was 
chosen to measure intelligibility in this study for a number of reasons: it is easy to administer, 
provides a quantifiable measure of intelligibility, and scores can be directly compared across 
participants.  The CSIM requires the SLT to select a word list at random from a choice of 200 
lists and ask the participant to repeat the 50 words spoken by the SLT.  An unfamiliar adult then 
listens to a recording of the 50 imitated words and identifies which word was spoken from 12 
phonetically-similar words.  For the participants in this study, all of whom presented with 
language impairment, the lists would have contained words which were unfamiliar to them and 
therefore the test, in parts, functionally became a measure of non-word repetition rather than 
a measure of intelligibility.  Wild et al. (2018) believe that a single test cannot capture all 
aspects of intelligibility in DS due to many contributory factors.  An approach adopting both 
analytic and subjective measures might provide more insights into intelligibility and also be 
capable of detecting any meaningful post-intervention change.  A single-word identification test 
using simple consonant-vowel (CV), VC and CVC known target stimuli (as in Wild et al. 2018) 
presented both aurally and in pictorial and written format, could provide an objective measure 
of the child’s speech whereas a parental questionnaire such as the Intelligibility in Context Scale 
(ICS: McLeod, Harrison and McCormack 2012), which uses an interval scale, could identify any 
change in the severity of the communication problem.   
The purpose of any speech intervention study is to produce measurable gains in participants.  
An important design feature of this study was the requirement to assess changes in speech 
production not only post-therapy, but also 3- and 6-month post-therapy in order to investigate 
both the maintenance of any improvements and any further changes. Over the course of the 
study, measurable gains were made by children in all three groups: some gains were 
maintained, some furthered, and some lost over the 9 months of monitoring.  Whilst changes in 
performance across and within groups did not always reach statistical significance, examination 
of individual changes in PCC scores revealed important differences in the groups that were not 
captured by the statistics.   The findings from these qualitative analyses are encouraging and 
suggest further investigation with larger numbers is warranted.  
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CONCLUSION 
This research aimed to evaluate the effectiveness of EPG-based and EPG-informed therapy for 
improving speech production in 27 school-aged children with DS. By the very nature of the 
study, we started with a limited number of participants who demonstrated a variability in 
scores much greater than anticipated, with this in turn greatly decreasing our chances of 
identifying any statistically significant differences in performance over time.  Perhaps Howard 
(1986) was right when he wrote, “it is not sensible to investigate the effects of a set of 
heterogeneous treatment techniques applied to a heterogeneous group of subjects measuring 
improvement with generalised and insensitive assessment techniques” (p.89).  This 
notwithstanding, the qualitative analyses of individual gains presented here are encouraging 
and will hopefully stimulate further investigation of intervention techniques to improve the 
speech of individuals with DS.  The results from this study, along with the findings from Terband 
et al. (2018), should be taken as evidence that individuals with DS can continue to improve their 
speech production and intelligibility into adolescence and adulthood.  This should be reflected 
in future management plans and is paramount for full integration into communities, 
educational progress and improved employment prospects.     
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